These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1977430)

  • 41. Towards improved control of atrial fibrillation.
    Channer KS; Papouchado M; James MA; Pitcher DW; Rees JR
    Eur Heart J; 1987 Feb; 8(2):141-7. PubMed ID: 3552679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
    Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
    Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.
    Lewis RV; Laing E; Moreland TA; Service E; McDevitt DG
    Eur Heart J; 1988 Mar; 9(3):279-83. PubMed ID: 3289931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of verapamil and digoxin in the treatment of atrial fibrillation.
    Lewis R; Lakhani M; Moreland TA; McDevitt DG
    Eur Heart J; 1987 Feb; 8(2):148-53. PubMed ID: 3552680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of fast heart rate episodes during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Alferness CA; Camm AJ; Malik M
    Heart; 1998 May; 79(5):497-501. PubMed ID: 9659199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent.
    David D; Segni ED; Klein HO; Kaplinsky E
    Am J Cardiol; 1979 Dec; 44(7):1378-82. PubMed ID: 41449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation. dl-Sotalol Atrial Fibrillation Study Group.
    Brodsky M; Saini R; Bellinger R; Zoble R; Weiss R; Powers L
    Am Heart J; 1994 Mar; 127(3):572-7. PubMed ID: 8122604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation.
    Murgatroyd FD; Gibson SM; Baiyan X; O'Nunain S; Poloniecki JD; Ward DE; Malik M; Camm AJ
    Circulation; 1999 Jun; 99(21):2765-70. PubMed ID: 10351970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
    James MA; Channer KS; Papouchado M; Rees JR
    Eur Heart J; 1989 Jan; 10(1):83-90. PubMed ID: 2702970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary study of the efficacy of xamoterol in bradycardia-tachycardia syndrome.
    Mizutani N; Kobayashi T; Watanabe T
    Br J Clin Pharmacol; 1994 Sep; 38(3):285-7. PubMed ID: 7826834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
    Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
    Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    J Intern Med; 1989 Nov; 226(5):331-5. PubMed ID: 2572666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
    Farshi R; Kistner D; Sarma JS; Longmate JA; Singh BN
    J Am Coll Cardiol; 1999 Feb; 33(2):304-10. PubMed ID: 9973007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of xamoterol in Shy-Drager syndrome.
    Obara A; Yamashita H; Onodera S; Yahara O; Honda H; Hasebe N
    Circulation; 1992 Feb; 85(2):606-11. PubMed ID: 1346511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
    Shettigar UR; Toole JG; Appunn DO
    Am Heart J; 1993 Aug; 126(2):368-74. PubMed ID: 8101692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of ICI 118,587, a new beta-adrenoceptor partial agonist in man.
    Sasayama S; Yokawa S; Akiyama M; Mikawa M; Sakai O
    Jpn Circ J; 1986 Jul; 50(7):636-43. PubMed ID: 2877103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.